Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionMan Group plc
Latest Disclosed Ownership806,484 shares
Latest Disclosed Value $ 11,661,759
Man Group plc reports 101.62% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 15, 2026 - Man Group plc filed a 13F-HR form disclosing ownership of 806,484 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $11,661,759 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 400,000 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 101.62% during the quarter. The current value of the position is $11,685,953 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 806,484 406,484 101.62 11,662 104.72 0.0212
2026-02-17 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 400,000 400,000 5,696 0.0097
2025-08-14 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -1,018,301 -100.00 0 -100.00
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,018,301 962,860 1,736.73 8,309 1,491.76 0.0211
2025-02-14 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 55,441 -680,887 -92.47 522 -93.36 0.0014
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 736,328 7,864 195.16 0.0205
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,665 -4.65 0.0083
2023-08-14 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 222,504 222,504 2,795 0.0086
2023-05-15 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -290,732 -100.00 0 -100.00
2023-02-14 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 290,732 185,635 176.63 3,550 223.52 0.0127
2022-11-14 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 105,097 1,097 459.69 0.0051
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 196 0.0008
2021-05-17 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -213,720 -100.00 0 -100.00
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 213,720 -296,226 -58.09 4,935 -31.47 0.0217
2020-11-16 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 509,946 -12,898 -2.47 7,201 -8.66 0.0283
2020-08-14 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 522,844 288,880 123.47 7,884 264.66 0.0398
2020-05-15 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 233,964 -56,134 -19.35 2,162 -23.50 0.0140
2020-02-18 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 290,098 20,401 7.56 2,826 30.65 0.0093
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 269,697 -21,664 -7.44 2,163 -40.51 0.0080
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 291,361 156,176 115.53 3,636 97.72 0.0131
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 135,185 -11,715 -7.97 1,839 30.70 0.0070
2019-02-14 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 146,900 -71,886 -32.86 1,407 -46.81 0.0063
2018-11-14 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 218,786 180,351 469.24 2,645 340.83 0.0097
2018-08-14 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 38,435 -239,243 -86.16 600 -85.64 0.0025
2018-05-15 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 277,678 277,678 4,177 0.0191
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.